The cell invasion and migration assays market
Roots
Analysis has announced the addition of the “Cell
Invasion and Migration Assays Market, 2022–2035†report to its list of offerings.
Owing to several advantages offered
by cell invasion and migration assays in analyzing
and quantifying cellular mechanisms, industry stakeholders have undertaken
numerous R&D initiatives focused on exploiting the use of such assays to
expediate discovery timelines and optimize the total development cost.
For additional details, please
visit
https://www.rootsanalysis.com/reports/cell-invasion-and-migration-assays-market.html
Considering the various
advantages offered by these cell-based assays, researchers across the globe have undertaken
several initiatives to use these platforms for the diagnosis of a myriad of
disease indications. The advancements in various technologies have propelled
life science companies to use these assays in the drug discovery process, to
enable the identification of potential lead candidates.
Key Market Insights
Presently, more than 80% of the
total assay providers are based in North America
This segment of the industry is
dominated by the presence of companies that were established pre-2000 (64%),
followed by firms established during 2000-2010 (27%). In addition, most of the
players engaged in this domain are small firms (less than 100 employees),
representing over 45% of the total assay providers.
Currently, over 80 cell invasion and
migration assays are available in the market
It is worth noting that most of the
cell invasion and migration assays are currently being used for tumor studies
(89%), followed by those employed for screening purposes (79%). Further, most of the assays are being developed for adherent
cell cultures (48%), followed by those being manufactured for both adherent and
suspension cell cultures (40%).
55% players claim to be capable of
offering both cell invasion as well as cell migration assays
64% of the cell invasion and
migration assays can be stored under frozen temperature (-18°C to -40°C),
followed by those stored under refrigerated conditions (+1°C to +18°C) (36%).
Further, it is worth noting that most of the cell invasion and migration assays
are being used to conduct 100 tests (37%). This was followed by assays being developed
to conduct 12 (35%) and 96 tests (23%).
Over 650 articles focused on cell
invasion and migration assays have been published, since 2021
Majority
of the scientific literature published in this domain was focused on research
(96%), followed by review articles (4%). It is worth mentioning that articles
related to cell invasion and migration assays have been affiliated by over 300
universities.
Patents
filed / granted for cell invasion and migration assays have
increased at a CAGR of more than 45%, since 2017
Of
the total, around 55% of the patents were applications, followed by those that
have been granted approval (45%). Around 63% of these intellectual property
documents were filed / granted in North America; with the maximum number of
patents having been filed in the US, since 2017.
More than 690 grants have been
awarded to support the ongoing research efforts in this domain
Several non-profit organizations
have extended financial support to aid the research related to cell invasion
and migration assays. It is worth mentioning that NCI emerged as the most
prominent non-profit organization, having awarded over 60% of grants, followed
by NIGMS (17%).
North America and Asia-Pacific are
anticipated to capture over 70% of the market share, in 2035
In terms of type of assay, the
current market is driven by cell invasion assays (56%); this trend is unlikely
to change in the foreseen future. Further, based on application area, assays
intended for tumor studies are likely to have the maximum revenue generation
potential (64%) in the overall market in 2035.
Key Questions Answered
§ Which
companies are engaged in offering cell invasion and migration assays kits?
§ What
is the most common assay format (in terms of number of wells) offered by cell
invasion and migration assay providers?
§ What
are the key geographical regions where cell invasion and migration assay
providers are located?
§ What
is the evolving trend of publications focused on cell invasion and migration
assays?
§ Which
companies are actively filing patents to drive innovation in the field of cell
invasion and migration assays?
§ What
are the key factors influencing the price of cell invasion and migration assays?
§ What
are the key challenges associated with cell invasion and migration assays?
§ How
is the current and future market opportunity likely to be distributed across
key market segments?
The financial opportunity within the cell invasion
and migration assays market has been analyzed across the following segments:
§ Type of Assay
§ Cell Invasion Assay
§ Cell Migration Assay
§ Application Area
§ Drug Discovery
§ Screening
§ Tumor Study
§ Detection Method Used
§ Colorimetry
§ Fluorometry
§ Key Geographical Regions
§ North America
§ Europe
§ Asia-Pacific
§ Latin America
§ MENA
§ Rest of the World
The report includes profiles of key
players (listed below); each profile features an overview of the company,
details related to its product portfolio dedicated to cell invasion and
migration assays, recent developments and an informed future outlook.
§ Abcam
§ BioVision
§ Enzo
Life Science
§ MilliporeSigma
§ R&D
Systems
§ Sigma-Aldrich
For
additional details, please visit
https://www.rootsanalysis.com/reports/cell-invasion-and-migration-assays-market.html
You may also be interested in the
following titles:
1.
Targeted protein degradation
market, 2022-2035
2.
Cell Therapy Manufacturing
Market, 2021-2030
3.
Single-Use
Upstream Bioprocessing Technology / Equipment Market, 2022-2035
About Roots Analysis
Roots Analysis is one of the fastest growing market
research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at [email protected]
Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
Article comments